Ovid Therapeutics Rockets 19% on Game-Changing Epilepsy Drug Breakthrough – Why This Could Shake Up Brain Health Investing
Folks, if you're glued to the markets this morning like I am, you've probably spotted that wild mover: Ovid Therapeutics (OVID). As of this writing, shares are up a whopping 19% to around $1.96, and it's not hard to see why. The biotech world just got a jolt of...